References
- Garrett J W, Drossman D A. Health status in inflammatory bowel disease: biological and behavioural considerations. Gastroenterology 1990; 99: 90–6
- Torrance G, Markham B, Feeny D, Rosenbloom D, Gafni A. Risk-benefit and Quality of Life analyses of prescription drugs. Health and Welfare Canada., Ottawa 1990
- Guyatt G H, Mitchell A, Irvine E J, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989; 96: 804–10
- Irvine E J, Feagan B, Rochon J, et al. Quality of Life: a valid and reliable measure of therapeutic efficacy in the treatment of IBD. Gastroenterology 1994; 106: 287–96
- Fitzpatrick R, Fletcher A, Gore S, et al. Quality of Life measures in health care I: Applications and issues in assessment. Br Med J 1992; 305: 1074–7
- Kohler L W, Pemberton J H, Zinsmeister A R, Kelly K A. Quality of Life after proctocolectomy. Gastroenterology 1991; 101: 679–84
- Torrance G W, Thomas W H, Sackett D LS. A utility maximization model for evaluation of health care programs. Health Res 1972; 7: 118–33
- Bergner M, Bobbitt R A, Carter W B, Bilson B S. The Sickness Impact Profile: Development and final revision of a health status measure. Med Care 1981; 19: 787–805
- Irvine E J, Donnelly M. Quality of Life is comparable impaired in patients with ulcerative colitis and irritable bowel syndrome. Gastroenterology. 1994; 106: A517
- Irvine E J, Zhou Q, Thompson A. The Short IBDQ: a Quality of Life instrument for community physicians managing inflammatory bowel disease. Am J Gastroenterol 1996